Literature DB >> 22678465

Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area.

Ichiro Miyajima1, Takumi Kawaguchi, Ako Fukami, Yumiko Nagao, Hisashi Adachi, Satoshi Sasaki, Tsutomu Imaizumi, Michio Sata.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) affects glucose and lipid metabolism in vitro; however, it is unclear whether HCV infection is associated with insulin resistance and atherosclerosis at the population level. We aimed to investigate this association in a Japanese cohort of the Seven Countries Study, and our investigation was conducted in Tanushimaru, an HCV hyperendemic area.
METHODS: A total of 1908 inhabitants of Tanushimaru were classified into 3 groups according to HCV infection status: those who were uninfected (n = 1780), those with transient infection (n = 88), and those with chronic infection (n = 40). Insulin resistance and atherosclerosis were evaluated by homeostasis model assessment for insulin resistance (HOMA-IR) and carotid intima-media thickness (IMT), respectively. Intergroup differences in variables were evaluated by age- and sex-matched multivariate regression analysis.
RESULTS: Significant intergroup differences were seen in fasting glucose and insulin levels. The HOMA-IR value was significantly higher in the group with chronic infection than the values in the uninfected and transiently infected groups (3.0 ± 0.39 vs. 1.3 ± 0.03 vs. 1.5 ± 0.14; P < 0.001). In contrast, low-density lipoprotein (LDL)-cholesterol and triglyceride levels were significantly lower in the group with chronic infection than the levels in the other groups. IMT was reduced in the group with chronic infection, with a significant intergroup difference (0.67 ± 0.02 vs. 0.71 ± 0.003 vs. 0.72 ± 0.01 mm; P = 0.003).
CONCLUSIONS: This population-based study in an HCV hyperendemic area revealed that chronic HCV infection was associated with severe insulin resistance and with mild atherosclerosis, suggesting a unique characteristic of HCV-related metabolic abnormality.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22678465     DOI: 10.1007/s00535-012-0610-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  44 in total

Review 1.  Hepatitis C: a metabolic liver disease.

Authors:  Steven A Weinman; L Maria Belalcazar
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

Review 2.  Branched-chain amino acids as pharmacological nutrients in chronic liver disease.

Authors:  Takumi Kawaguchi; Namiki Izumi; Michael R Charlton; Michio Sata
Journal:  Hepatology       Date:  2011-06-23       Impact factor: 17.425

3.  The role of obesity in the association of cardiovascular risk factors and glucose intolerance in small Japanese and North American communities.

Authors:  H Adachi; F C Goetz; D R Jacobs; M Tsuruta; Y Hirai; Y Fujiura; T Imaizumi
Journal:  Diabetes Res Clin Pract       Date:  2000-07       Impact factor: 5.602

4.  Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries.

Authors:  A Keys; C Aravanis; H W Blackburn; F S Van Buchem; R Buzina; B D Djordjević; A S Dontas; F Fidanza; M J Karvonen; N Kimura; D Lekos; M Monti; V Puddu; H L Taylor
Journal:  Acta Med Scand Suppl       Date:  1966

Review 5.  Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models.

Authors:  G M Reaven
Journal:  Diabetes Care       Date:  1991-03       Impact factor: 19.112

6.  Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese.

Authors:  Kai-Chien Yang; Ming-Fong Chen; Ta-Chen Su; Jiann-Shing Jeng; Bau-Show Hwang; Lian-Yu Lin; Chiau-Suong Liau; Yuan-Teh Lee
Journal:  Atherosclerosis       Date:  2006-11-28       Impact factor: 5.162

7.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

8.  Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population.

Authors:  M E Allison; T Wreghitt; C R Palmer; G J Alexander
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

9.  Prognostic significance of diabetes in patients with cirrhosis.

Authors:  G Bianchi; G Marchesini; M Zoli; E Bugianesi; A Fabbri; E Pisi
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

10.  Association between hepatitis C virus core protein and carotid atherosclerosis.

Authors:  Yuko Ishizaka; Nobukazu Ishizaka; Eiko Takahashi; Tadao Unuma; Ei-ichi Tooda; Hideki Hashimoto; Ryozo Nagai; Minoru Yamakado
Journal:  Circ J       Date:  2003-01       Impact factor: 2.993

View more
  19 in total

Review 1.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 2.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

3.  Hepatic artery aneurysm in a patient with hepatitis C liver cirrhosis: report of a case.

Authors:  Yu Saito; Tomoharu Yoshizumi; Noboru Harada; Hiroto Kayashima; Koji Yamasaki; Noriaki Sadanaga; Hiroshi Matsuura; Kenichiro Okadome
Journal:  Clin J Gastroenterol       Date:  2013-03-09

4.  Relationship of hepatitis C virus infection with diabetes in the U.S. population.

Authors:  Constance E Ruhl; Andy Menke; Catherine C Cowie; James E Everhart
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

5.  Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.

Authors:  Kara W Chew; Debika Bhattacharya; Kathleen A McGinnis; Tamara B Horwich; Chi-Hong Tseng; Judith S Currier; Adeel A Butt
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-11       Impact factor: 2.205

Review 6.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 7.  Infectious burden and atherosclerosis: A clinical issue.

Authors:  Rosa Sessa; Marisa Di Pietro; Simone Filardo; Ombretta Turriziani
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

Review 8.  Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature.

Authors:  Robert J Wong; Fasiha Kanwal; Zobair M Younossi; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2014-06-04       Impact factor: 3.199

Review 9.  Infectious and coronary artery disease.

Authors:  Mohammad Saeid Rezaee-Zavareh; Mohammad Tohidi; Amin Sabouri; Mahdi Ramezani-Binabaj; Mohsen Sadeghi-Ghahrodi; Behzad Einollahi
Journal:  ARYA Atheroscler       Date:  2016-01

Review 10.  Metabolic alterations and hepatitis C: From bench to bedside.

Authors:  Ming-Ling Chang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.